Clinical Trial Update: Fecal Microbiota Transplant for Improvement of Metabolism [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating fecal microbiota transplant to improve metabolic outcomes in obesity has been completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obesity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-25